1 |
How a VOICE for clinical pharmacology turns into a RECIPE for its developmentHow a VOICE for clinical pharmacology turns into a RECIPE for its development
Jeffrey K AronsonJeffrey K Aronson
KMSID: 1082616 Transl Clin Pharmacol. 2016;24(1):1-6. Published online 2016 March 15 DOI: http://dx.doi.org/10.12793/tcp.2016.24.1.1 |
|
7 |
Clinical pharmacologic aspects of immune checkpoint inhibitors in cancer therapyClinical pharmacologic aspects of immune checkpoint inhibitors in cancer therapy
Kyu-pyo Kim, Hun JungKyu-pyo Kim, Hun Jung
KMSID: 1082644 Transl Clin Pharmacol. 2016;24(1):7-12. Published online 2016 March 15 DOI: http://dx.doi.org/10.12793/tcp.2016.24.1.7 |
|
13 |
Brief introduction to current pharmacogenomics research toolsBrief introduction to current pharmacogenomics research tools
Eun-Young Cha, Hye-Eun Jeong, Woo-Young Kim, Ho Jung Shin, Ho-Sook Kim, Jae-Gook ShinEun-Young Cha, Hye-Eun Jeong, Woo-Young Kim, Ho Jung Shin, Ho-Sook Kim, Jae-Gook Shin
KMSID: 1082623 Transl Clin Pharmacol. 2016;24(1):13-21. Published online 2016 March 15 DOI: http://dx.doi.org/10.12793/tcp.2016.24.1.13 |
|
22 |
Development of a validated liquid chromato-graphy–tandem mass spectrometry assay for the quantification of simvastatin acid, the active metabolite of simvastatin, in human plasmaDevelopment of a validated liquid chromato-graphy–tandem mass spectrometry assay for the quantification of simvastatin acid, the active metabolite of simvastatin, in human plasma
Hyun-Jung Park, Ae-Kyung Hwang, A-Reum Kim, Soo-Hyeon Kim, Eun-Hwa Kim, Sang-Heon Cho, Jong-Lyul Ghim, Sangmin Choe, Jin-Ah Jung, Seok-Joon Jin, Kyun-Seop Bae, Hyeong-Seok LimHyun-Jung Park, Ae-Kyung Hwang, A-Reum Kim, Soo-Hyeon Kim, Eun-Hwa Kim, Sang-Heon Cho, Jong-Lyul Ghim, Sangmin Choe, Jin-Ah Jung, Seok-Joon Jin, Kyun-Seop Bae, Hyeong-Seok Lim
KMSID: 1082637 Transl Clin Pharmacol. 2016;24(1):22-29. Published online 2016 March 15 DOI: http://dx.doi.org/10.12793/tcp.2016.24.1.22 |
|
30 |
Development and validation of a UPLC-MS/ MS method for the quantification of acetaminophen in human plasma and its application to pharmacokinetic studiesDevelopment and validation of a UPLC-MS/ MS method for the quantification of acetaminophen in human plasma and its application to pharmacokinetic studies
Jaemin Cha, Bo Kyung Kim, Mi-Ri Gwon, Joomi Lee, Boram Ohk, Woo Youl Kang, Mi-sun Lim, Sook Jin Seong, Hyun-Ju Kim, Hae Won Lee, Young-Ran YoonJaemin Cha, Bo Kyung Kim, Mi-Ri Gwon, Joomi Lee, Boram Ohk, Woo Youl Kang, Mi-sun Lim, Sook Jin Seong, Hyun-Ju Kim, Hae Won Lee, Young-Ran Yoon
KMSID: 1082638 Transl Clin Pharmacol. 2016;24(1):30-36. Published online 2016 March 15 DOI: http://dx.doi.org/10.12793/tcp.2016.24.1.30 |
|
37 |
HPLC-UV method for the simultaneous determinations of ascorbic acid and dehydroascorbic acid in human plasmaHPLC-UV method for the simultaneous determinations of ascorbic acid and dehydroascorbic acid in human plasma
Yunjeong Kim, Min-Gul KimYunjeong Kim, Min-Gul Kim
KMSID: 1082639 Transl Clin Pharmacol. 2016;24(1):37-42. Published online 2016 March 15 DOI: http://dx.doi.org/10.12793/tcp.2016.24.1.37 |
|
43 |
Screening study for genetic polymorphisms affecting pharmacokinetics of simvastatinScreening study for genetic polymorphisms affecting pharmacokinetics of simvastatin
Sohee Im, Bo-Hyung Kim, Kidong Lee, KyuBum Kwack, Sung-Vin YimSohee Im, Bo-Hyung Kim, Kidong Lee, KyuBum Kwack, Sung-Vin Yim
KMSID: 1082640 Transl Clin Pharmacol. 2016;24(1):43-54. Published online 2016 March 15 DOI: http://dx.doi.org/10.12793/tcp.2016.24.1.43 |
|
55 |
Mixed–effects analysis of increased rosuvastatin absorption by coadministered telmisartanMixed–effects analysis of increased rosuvastatin absorption by coadministered telmisartan
Wan-Su Park, Dooyeon Jang, Seunghoon Han, Yim Dong-SeokWan-Su Park, Dooyeon Jang, Seunghoon Han, Yim Dong-Seok
KMSID: 1082641 Transl Clin Pharmacol. 2016;24(1):55-62. Published online 2016 March 15 DOI: http://dx.doi.org/10.12793/tcp.2016.24.1.55 |
|